 Regional Court of Dusseldorf has ruled in favor of NuCana plc NASDAQ: NCNA, stating that Gilead Sciences Ireland UC and Gilead Sciences GmbH infringed NuCanas composition of matter claims in European Patent 2955190 through their sales of Sovaldi, Harvoni, Vosevi and. 